|
2016
|
Invention
|
Fusion polypeptide comprising the extracellular binding domain of growth hormone receptor.
The i... |
|
|
Invention
|
Fusion polypeptide comprising the extracellular binding domain of growth hormone receptor. The in... |
|
|
Invention
|
Growth hormone fusion proteins with growth hormone receptor agonist activity. We disclose growth ... |
|
2012
|
Invention
|
Growth hormone fusion proteins. We disclose growth hormone [GH] fusion proteins that have increas... |
|
|
Invention
|
Growth hormone receptor antagonists. We disclose growth hormone fusion proteins that have increas... |
|
|
Invention
|
Modified receptor fusion proteins. We disclose growth hormone fusion proteins that have increased... |
|
2010
|
Invention
|
Interferon lambda fusion polypeptides.
The disclosure relates to interferon lambda fusion polype... |
|
2009
|
Invention
|
Glp-1 fusion polypeptides.
We describe nucleic acid molecules that encode fusion polypeptides co... |
|
|
Invention
|
Glp-1 fusion polypeptides. We describe nucleic acid molecules that encode fusion polypeptides com... |
|
|
Invention
|
Interleukin fusion polypeptides. The disclosure relates to interleukin fusion polypeptides and di... |
|
|
Invention
|
Insulin fusion polypeptides.
We disclose insulin fusion polypeptides and dimers; nucleic acid mo... |
|
|
Invention
|
Insulin fusion polypeptides. We disclose insulin fusion polypeptides and dimers; nucleic ac... |
|
|
Invention
|
Insulin fusion polypeptides. We disclose insulin fusion polypeptides and dimers; nucleic acid mol... |
|
|
Invention
|
Thyroid stimulating hormone fusion proteins. We disclose TSH fusion proteins comprising TSHα and/... |
|
|
Invention
|
Modified fusion polypeptides.
Chimeric polypeptides wherein the polypeptides comprise a modified... |
|
|
Invention
|
Modified linkers.
We describe modified peptide linkers that function to link at least first and ... |
|
|
Invention
|
Modified linkers. We describe modified peptide linkers that function to link at least first and s... |
|
2008
|
Invention
|
Peptide fusion proteins. We disclose fusion proteins comprising a peptide comprising a binding do... |
|
|
Invention
|
Prolactin fusion proteins. We disclose prolactin fusion proteins that have agonist or antagonist ... |
|
|
Invention
|
Modified growth hormone polypeptides. We describe modified growth hormone fusion proteins and dim... |
|
|
Invention
|
Modified growth hormone polypeptides. We describe modified growth hormone fusion proteins a... |
|
|
Invention
|
Insulin-like growth factor fusion proteins.
This disclosure relates to insulin-like growth facto... |
|
|
Invention
|
Interferon fusion proteins.
The disclosure relates to interferon fusion polypeptides and dimers;... |
|
|
Invention
|
Interferon fusion proteins. The disclosure relates to interferon fusion polypeptides and dimers; ... |
|
|
Invention
|
Insulin-like growth factor fusion proteins. This disclosure relates to insulin-like growth factor... |
|
|
Invention
|
Erythropoietin.
This disclosure relates to erythropoietin (EPO) fusion polypeptides; nucleic aci... |
|
|
Invention
|
Erythropoietin fusion proteins. This disclosure relates to erythropoietin (EPO) fusion polypeptid... |
|
|
Invention
|
Granulocyte colony stimulating factor.
We disclose granulocyte colony stimulating factor fusion ... |
|
|
Invention
|
Granulocyte colony stimulating factor. We disclose granulocyte colony stimulating factor fusion p... |
|
|
Invention
|
Leptin fusion proteins.
The disclosure relates to leptin fusion polypeptides; nucleic acid molec... |
|
|
Invention
|
Leptin fusion proteins. The disclosure relates to leptin fusion polypeptides; nucleic acid molecu... |
|
|
Invention
|
Fusion protein comprising growth hormone and growth hormone receptor. Agents which bind to cell s... |
|
|
Invention
|
Growth hormone fusion proteins. We disclose growth hormone fusion proteins that have increased in... |
|
2007
|
Invention
|
Growth factor.
We describe a chimeric protein comprising a growth hormone polypeptide linked to ... |
|
|
Invention
|
Growth factor. We describe a chimeric protein comprising a growth hormone polypeptide linked to a... |
|
|
P/S
|
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic ... |
|
|
Invention
|
Polypeptide antagonist.
We describe a circularly permuted growth hormone polypeptide antagonist;... |
|
|
Invention
|
Polypeptide antagonist. We describe a circularly permuted growth hormone polypeptide antagonist; ... |
|
|
Invention
|
Leptin ligand. We describe ligands that specifically bind leptin and/or the leptin receptor there... |
|
2006
|
Invention
|
Polypeptide variants.
The invention relates to the provision of oligomeric polypeptides (dimers,... |
|
2005
|
Invention
|
Linkers.
We disclose therapeutic polypeptides comprising at least two domains capable of binding... |
|
|
Invention
|
Linkers. We disclose therapeutic polypeptides comprising at least two domains capable of bi... |
|
|
Invention
|
Linkers. We disclose therapeutic polypeptides comprising at least two domains capable of binding ... |
|
2004
|
Invention
|
Cytokine variant polypeptides.
We describe modified cytokine ligand polypeptides comprising a mo... |
|
|
Invention
|
Cytokine polypeptides and antibodies containing a signal sequence for the attachment of glycosylp... |
